2/24/2001 – Wall Street Journal Questions PMDD & Sarafem (Prozac)

IS SEVERE PMS, or premenstrual syndrome, a mental illness? Some
pharmaceutical companies and psychiatrists are treating it as one. In new
television ads, drug maker Eli Lilly is promoting the drug Sarafem to treat
the
problem, now dubbed Premenstrual Dysphoric Disorder (PMDD). But the
pink and purple pills aren’t a new drug — they are simply repackaged
Prozac,
the popular antidepressant.

Read More

02/15/2001 – RISKING KIDS' HEALTH FOR SAKE OF SCIENCE – AT WHAT COST?

TWO city research institutions will extend their tentacles into our
communities today, looking for hundreds of kids, some as young as 3, to use
as guinea pigs.

The experiments, to determine the safety and efficacy of Ritalin in
preschoolers, have advocates up in arms – they think researchers are playing
fast and loose with the brains of children.

Read More

02/15/2001 – Doctors Say Drug Trial's Approval was Backdated

The Nigerian doctor who supervised a 1996 Pfizer Inc. drug experiment on
desperately ill children said in an interview that his office created a
backdated ethics approval document that the American pharmaceutical company
later used to satisfy U.S. regulators and to justify its conduct of the
human testing.

Read More

1/17/2001 – Upcoming Radio Show & New Site for ICFDA

And this coming Sunday (or Monday, depending on what part of the country you are
in) I will the be guest on Art Bell’s Coast to Coast radio program. Ian Punnett
will be the host of the show so it should be good. He and I did a show together
a couple of weeks ago and he is an incredible interviewer. The interview will go
for three hours beginning at 11:00 PM Pacific Time. This is a national program
and is literally heard from coast to coast. To find a station in your area to
listen in or to listen online just go to www.artbell.com. (BTW if you have read
my book, you know that I do not encourage anyone to be awake during those hours
so get a tape ready to record the show and go to bed! 🙂 )

Read More

1/11/2001 – More Self Harm Seen with SSRI Therapy Than With Tricyclics

WESTPORT, CT (Reuters Health) Dec 28 – Significantly more
instances of deliberate self-harm occur in patients prescribed a
selective serotonin reuptake inhibitor (SSRI) than in those
prescribed a tricyclic antidepressant (TCA). In their report in the
December issue of the British Journal of Psychiatry, UK
investigators caution that the choice of antidepressant for
patients at risk should not be based solely on overdose toxicity.

Read More